Publications & Works

Articles 221
All (221)
SCI-E, SSCI, AHCI (166)
SCI-E, SSCI, AHCI, ESCI (195)
ESCI (29)
Scopus (197)
TRDizin (43)
Other Publications (8)

100. Türkiye Klinikleri

Türkiye Klinikleri , vol.1, no.1, pp.53-58, 2019 (Peer-Reviewed Journal)

105. Akut Graft Versus Host Hastalığı

Turkiye Klinikleri , vol.10, no.4, pp.221-227, 2017 (Peer-Reviewed Journal)

169. ERYTHROCYTE SEDIMENTATION RATE

NOBEL MEDICUS , vol.1, no.1, pp.4-8, 2005 (ESCI, Scopus) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 217

2. Lenalidomid ile ilişkili geç tip reaksiyon nedeniyle desensitizasyon yapılan hastaların uzun dönem takip sonuçları

XXXI. Uluslararası Katılımlı Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Türkiye, 26–30 Kasım 2025, 26 November 2025, (Summary Text)

3. LENALİDOMİD İLE İLİŞKİLİ GEÇ TİP REAKSİYON NEDENİYLE DESENSİTİZASYON YAPILAN HASTALARIN UZUN DÖNEM TAKİP SONUÇLARI

XXXI. Uluslararası Katılımlı ULUSAL ALERJİ VE KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Turkey, 26 - 30 November 2025, (Summary Text)

5. Multipl Miyelom'da Genetik Karmaşa: Optik Genom Haritalamanın Yeri

12. Hematolojik Onkoloji Kongresi, KKTC, Turkey, 02 October 2025, pp.134-137, (Summary Text)

10. Bir Taşla İki Kuş: Akalabrutinib ile KLL ve Anjiyoödem Kontrolü

51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.337-338, (Summary Text)

11. ASSESSMENT OF CHARACTERISTICS AND TREATMENT PATTERNS OF ADULT PATIENTS WITH ACQUIRED APLASTIC ANAEMIA IN TURKIYE (PLANE-TR STUDY)

51st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 30 March - 02 April 2025, vol.60, pp.247-248, (Summary Text)

12. Isatuximab subcutaneous by on-body injector in Relapsed/Refractory multiple myeloma in the Phase 3 iraklia study: Effect of body weight on pharmacokinetics and clinical outcome

67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 6 - 09 December 2025, vol.146, pp.5812-5813, (Summary Text)

13. Aberrant splicing due to ITK splice-site variant in a pediatric patient with secondary plasmablastic lymphoma: a case study

58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan, Italy, 24 - 27 May 2025, vol.33, pp.133, (Summary Text)

14. Allopurinol ilişkili SDRIFE (simetrik, ilaç ilişkili, intertriginöz ve fleksural ekzantem): Anımsanması gereken bir deri tepkimesi

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.50-51, (Summary Text)

15. Acil Dahiliye Kliniğine Trombotik Mikroanjiyopati Tanısı ile Başvuran Hastaların Tanısal Dağılımı: Tek Merkez Deneyimi

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.25-26, (Summary Text)

16. Hemofagositik lenfohistiyositoz gelişen metilmalonik asidemi hastası: Nadir bir olgu sunumu

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.32-33, (Summary Text)

17. Asitle prezente olan periferik T hücreli lenfomalar, başka türlü sınıflandırılmayan (PTCL NOS) nüksü olgusu

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.34, (Summary Text)

21. TIROTOKSIKOZDA PLAZMAFEREZ DENEYIMI

46. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 30 April - 04 May 2025, pp.202-203, (Summary Text)

22. Hemophagocytic lymphohistiocytosis syndrome (HLH) in HIV-infected patients with Kaposi sarcoma: the first case series from a single centre in Turkey

35th Congress of the European Society of Clinical Microbiology and Infectious Diseases, Viyana, Austria, 11 April 2025, pp.4832, (Summary Text)

24. Erişkin yaşta tanı alan immün sistemin doğuştan kusurları hastalarının yönteiminde karşılaşılan problemler: Gerçek yaşamda zor vaka serisi

XXX. Uluslararası Katılımlı Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 27 November - 01 December 2024, (Summary Text)

25. Optical Genome Mapping in Newly Diagnosed Chronic Lymphocytic Leukemia

66th ASH Annual Meeting and Exposition, San Diego, CA, United States Of America, 7 - 10 December 2024, pp.6758, (Summary Text)

31. Kardiyak Amiloidozda Ani Ölümde İntrakardiyak Defibrilatör Etkisi: Olgu Sunumu

50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.294-295, (Summary Text)

33. Bağışıklığı Tam Hastada Eş Zamanlı Multipl Miyelom ve Kaposi Sarkomu

50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.302, (Summary Text)

37. Systemic AA Amyloidosis as a Complication of Idiopathic Multicentric Castleman's Disease

11th SOHO Türkiye Meeting, İstanbul, Turkey, 28 April 2024, vol.24, pp.427-428, (Summary Text)

41. Multipl miyelomda kemik iliği fibrozisinin ekstramedüller hastalık ile ilişkisi

25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.77-78, (Full Text) Sustainable Development

42. HLA heterozigotluğu bağırsak mikrobiyotasını etkiler mi?

18. TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Ankara, Turkey, 26 - 29 October 2023, pp.15-16, (Summary Text)

47. Cardiac AL amyloidosis experienced in the last decade from a single center

20th International Myeloma Society Annual Meeting, Atina, Greece, 27 - 30 September 2023, vol.23, pp.275, (Full Text)

48. NASOPHARYNGEAL PLASMACYTOMA WİTH TUMEFACTİVE AMYLOİDOSİS ("AMYLOİDOMA") PRESENTİNG WITH UNİLATERAL HEARİNG LOSS

IMS 20th Annual Meeting and Exhibition, Athens, Greece, 27 - 30 September 2023, pp.432, (Full Text)

49. THE GUT MICROBIOTA CHANGES DURİNG MULTIPLE MYELOMA TREATMENT

IMS 20TH Annual Meeting and Exhibition , Athens, Greece, 27 - 30 September 2023, vol.23, pp.258-259, (Full Text) Creative Commons License

50. CARDIAC AL AMYLOIDOSIS EXPERIENCED IN THE LAST DECADE FROM A SINGLE CENTER

IMS 20th Annual Meeting and Exhibition, Athens, Greece, 27 - 30 September 2023, pp.425, (Full Text)

51. TCL-223 Clonal CD4+ Cytotoxic T Lymphocytosis Concomitant With POEMS Syndrome: A Co-Existence of Key Findings for Relevance in the Pathogenesis

Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting, Texas, United States Of America, 06 September 2023, vol.23, pp.467-468, (Full Text)

52. The relationship of bone marrow fibrosis with extramedullary disease in multiple myeloma

28th Congress of the European Hematology Association (EHA 2023), Frankfurt, Germany, 08 June 2023, pp.1776, (Summary Text)

55. A different point of view: Facial paralysis as a manifestational of AL amyloidosis

Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.65, (Summary Text)

56. CXCL12 CHEMOKINE AND RELATIONSHIP WITH MULTIPLE MYELOM

Society of hematologic oncology, İstanbul, Turkey, 5 - 07 May 2023, pp.26, (Summary Text)

57. IMPACT OF EPITOPE MATCH ON STEM CELL TRANSPLANTATION

Society of hematologic oncology, İstanbul, Turkey, 5 - 07 May 2023, pp.33, (Summary Text)

58. A rare case of multiple myeloma presenting as a cranial nerve palsy

Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.61, (Summary Text)

59. Edinsel saf eritroit dizi aplazi tedavisi seyrinde Hodgkin Dışı Lenfoma: De novo? İmmunsupresif tedavi ilişkili?

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2023, Sapanca, Turkey, 09 March 2023, pp.29-30, (Summary Text)

60. Kan ürünleri transfüzyonları sorunlar ve çözümler

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2023, Sapanca, Turkey, 09 March 2023, pp.9-11, (Summary Text)

62. NADİR BİR İSKEMİK İNME NEDENİ: TROMBOTİK TROMBOSİTOPENİK PURPURA

58. ULUSAL NÖROLOJİ KONGRESİ , Antalya, Turkey, 19 - 24 November 2022, pp.326, (Summary Text)

70. The Effect Of Age And Gender Differences On The Distribution Of T And B Lymphocyte Subsets

5th International Molecular Immunology & Immunogenetics Congress, İzmir, Turkey, 20 - 22 October 2022, pp.55, (Summary Text)

72. Rare indications of Mepolizumab in eosinophilic disorders: A real-life study

World Allergy Congress 2022 İstanbul, İstanbul, Turkey, 13 October 2022, pp.164, (Summary Text)

73. An unusual ocular lymphoma, primary intravitreal lymphoma diagnosed incidentally

XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.30-31, (Summary Text)

74. Treatment of a patient diagnosed with Erdheim Chester’s Disease in cooperation with plastic surgery and hematology

XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.19, (Summary Text)

75. A rare presentation of systemic AL amyloidosis; Pulmonary AL amyloidosis

XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.19, (Summary Text)

81. POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME

Annual European Congress of Rheumatology (EULAR), Copenhagen, Denmark, 1 - 04 June 2022, no.73, pp.937-938, (Summary Text) Creative Commons License Sustainable Development

82. Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi

8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.88-89, (Summary Text)

84. HYPERGAMMAGLOBULINEMIA AND ALVEOLAR HEMORRHAGE IN THE COURSE OF INDOLENT LYMPHOMA IN A PATIENT PRESENTING WITH A GIANT HEPATIC MASS

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Turkey, 24 - 27 March 2022, pp.37-38, (Full Text)

86. Relationship between HLA and COVID-19 in unrelated bone marrow donors

Hacettepe Acta Medica- XVII. Congress of Medical Biology and Genetics, 28 - 31 October 2021, vol.52, pp.407-408, (Summary Text) Creative Commons License

88. AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B

XIIth Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 10 - 13 November 2021, pp.20, (Summary Text)

89. ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT

XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.77, (Summary Text)

90. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96, (Summary Text)

91.

Endokurs 5, Antalya, Turkey, 10 - 14 November 2021, pp.148, (Summary Text) Creative Commons License Sustainable Development

92. A CASE OF MULTI REGIONAL PRIMARY MUSCLE LYMPHOMA

XIIth Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 10 - 13 November 2021, pp.41, (Summary Text)

94. Preliminary Criteria for Macrophage Activation SyndromeAssociated with Coronavirus Disease-19

American College of Rheumatology 2021, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-4, (Summary Text) Creative Commons License Sustainable Development

97. A Case of Congenital Afibrinogenemia with Two Successful Spontaneous Delivery after Recurrent Pregnancy Losses

ISTH 2021 Congress, Pennsylvania, United States Of America, 17 - 21 July 2021, no.5, pp.312, (Summary Text)

98. A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection

American Transplant Congress 2021, United States Of America, 4 - 09 June 2021, vol.21, pp.451, (Summary Text)

100. Microbiota Analysis After Allogeneic Stem Cell Transplantation in Blood Diseases

Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, İstanbul, Turkey, 26 - 30 May 2021, pp.1-3, (Summary Text)

101. Blood and bone marrow donor regıstry of ıstanbul medıcal faculty actıvıty ın past 3 years.

HLA Dergisi, 34th European Immunogenetics and Histocompatibility Conference, 21 - 23 April 2021, pp.330, (Summary Text)

102. Erişkin kişide çene kemiğinde litik lezyon; diş hekimliğinden iç hastalıklarına multidisipliner yaklaşım

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2021, Online, Turkey, 11 March 2021, pp.35, (Summary Text)

103. CASTLEMAN HASTALIĞI’NIN NADIR BIR FORMU: TAFRO SENDROMU

Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, İstanbul, Turkey, 11 March 2021, (Summary Text)

105. COVID-19 hastalarında Antitrombin-III seviyelerinin prognostik önemi

20. Ulusal Yoğun Bakım E- Kongresi (uluslararası katılımı) , İstanbul, Turkey, 10 - 15 November 2020, pp.1, (Summary Text) Sustainable Development

113. LANGERHANS HÜCRELİ HİSTİYOSİTOZ: TEK MERKEZ DENEYİMİ

45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2019, pp.155-156, (Summary Text)

116. Clinical relevance of minor histocompatibility antigens

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)

117. Red blood cell alloantibodies in thalassemia major patients: an analysis from Istanbul

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)

122. Serological weak d phenotypes and RHD genotype frequency among Turkish blood donors

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)

123. Adult-onset ligneous gingivitis associated with plasma cell dyscrasia in the absence of plasminogen deficiency

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)

126. Late renal aspergilloma after autologous stem cell transplantion mimicking secondary malignancy

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)

128. Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.217-218, (Summary Text)

132. Secondary primary malignancies after autologous hematopoietic stem cell transplantation: Single center experience

44th Annual Meeting of the European Society for Blood and Marrow Transplantation, Lisbon, Portugal, 18 March 2018, (Summary Text)

134. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

IXth International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68, (Summary Text)

135. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68, (Summary Text)

136. Cancer-associated thrombotic microangiopathies for refractory thrombotic thrombocytopenic purpura differential diagnosis

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

139. Chimerism by lineage-specific analysis in the course of clinical outcome

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

140. Investigation of B-lymphocyte F-actin cell skeleton in multiple myeloma patients

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

141. qRT-PCR and STR-PCR chimerism method using after allogeneic hematopoietic stem cell transplantation

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

142. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

143. Evaluation of B and T cell chimerism after allogeneic stem cell transplantation in hematologic malignancies

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

144. Secondary primary malignancies after autologuous hematopoietic stem cell transplantation: Single center experience

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.368-369, (Summary Text)

145. Infectious epidemiology in Multiple Myeloma patients after Autologous Stem Cell Transplantation: A single-center analysis from Turkey

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.566-567, (Summary Text)

147. Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)

148. RNA sequencing and in silico analysis of Myeloma cells in multiple myeloma patients

XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye- Muğla, Turkey, 26 - 29 October 2017, pp.108, (Summary Text)

155. Hematopoetik Kök Hücre Nakli Başarısı üzerine HLA-DPB1 Uyumunun Etkisi

Türk Hematoloji Derneği 9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavi Kongresi, Antalya, Turkey, 05 March 2016, (Full Text)

156. KİMERİZM ANALİZİ İÇİN SHORT TANDEM REPEAT-PCR VE KANTİTATİF-REAL TIME PCR YÖNTEMLERİNİN KARŞILAŞTIRILMASI

9. Ulusal Kemik İliği Transplantasonu ve Kök Hücre Tedavileri Kongresi, Antalya, Turkey, 3 - 05 March 2016, pp.136, (Summary Text)

161. Hematopoetik kök hücre nakli (HKHN) yapılan hastalardaki infeksiyonlardan sorumlu bakterilerin değerlendirilmesi

KLİMİK 2015 XVII. TÜRK KLİNİK MİKROBİYOLOJİ VE İNFEKSİYON HASTALIKLARI KONGRESİ, Antalya, Turkey, 25 - 29 March 2015, pp.297-298, (Summary Text)

162. HLA-A allele mismatch (7/8 or 9/10) is the second best option after 8/8 or 10/10 matched unrelated donors: An analysis on results from Turkish centers

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text)

163. The impact of donor specific anti-HLA antibodies on the outcome of allogeneic stem cell transplantation

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text)

166. RESTORING OF DONOR CHIMERISM BY THYROSINE KINASE INHIBITOR TREATMENT IN RELAPSED CHRONIC MYELOID LEUKEMIA AFTER ALLOGENIC TRANSPLANTATION

28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.56, (Summary Text)

167. INVESTIGATION OF LINEAGE-SPECIFIC AND PERIPHERAL BLOOD CHIMERISM ANALYSIS IN POST-STEM CELL TRANSPLANT PATIENTS

28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.55-56, (Summary Text)

168. THE IMPACT OF DONOR SPECIFIC ANTI-HLA AND ANTI-GSTT1 ANTIBODIES ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION

28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.56-57, (Summary Text)

170. Allogegneik kök hücre nakli sonrası anti-HLA ve anti-GSTT1 antikorlarının nakil başarısı üzerine etkisi.

8. Ulusal Kemik İliği Transplantasyonu ve Kök hücre tedavileri kongresi, Antalya, Turkey, 6 - 08 March 2014, pp.153-154, (Full Text)

171. IMPACT OF GLUTATHIONE S-TRANSFERASE AND CYTOCHROME P450 POLYMORPHISMS ON CLINICAL OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION

40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy, 30 March - 02 April 2014, vol.49, (Summary Text)

172. CHIMERISM STATUS AND ITS EFFECT ON CLINICAL OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION

40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy, 30 March - 02 April 2014, vol.49, (Summary Text)

175. Lenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)

176. Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)

178. TYPING OF RELATIVES OF PATIENTS BEING CONSIDERED FOR ALLOGENEIC STEM CELL TRANSPLANTATION

Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, United Kingdom, 31 May - 03 June 2012, vol.79, pp.441-442, (Summary Text)

180. How did the sibling donor's manage their lives?: a 13-year follow-up survey on the impact of giving stem cell

38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, Switzerland, 1 - 04 April 2012, vol.47, (Summary Text)

181. İntravasküler Lenfoma Olgusu-tanıda PET-BT’nin Yeri.

13. Ulusal İç Hastalıkları Kongresi, Turkey, 5 - 09 October 2011, (Summary Text)

182. Bacillus cereus Catheter Related Bloodstream Infection in a Patient with Acute Lymphoblastic Leukemia

8th International Symposium on Antimicrobial Agents and Resistance (ISAAR), Seul, South Korea, 6 - 08 April 2011, pp.292, (Full Text)

183. The evaluation of the incidence of recurrent aphthous lesions in patients with haematinic deficiencies

10th Biennial Conference of EAOM Incorporating the World Workshop on Oral Medicine, United Kingdom, (Full Text)

185. Miyeloid Lösemilerde Kromozomal Anomaliler.

XI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 28 - 31 October 2009, pp.57-58, (Full Text)

186. İstanbul Tıp Fakültesi Kemik İliği Bankası (İTF KİBANK).

35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 7 - 10 October 2009, pp.1-2, (Full Text)

187. Akut Miyeloid Lösemide Kromozom Anormalliklerin Sıklığı Yaşla ve Cinsiyetle Değişir mi?

X. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 6 - 09 September 2007, pp.223, (Full Text)

188. Does the frequency of chromosomal aberrations change with age and gender in acute myeloid leukemia?

21st European Immunogenetics and Histocompatibility Conference, Barcelona, Spain, 5 - 08 May 2007, vol.69, pp.461, (Summary Text)

189. Variant Philadelphia translocations in patients with Chronic Myeloid Leukemia

6th European Cytogenetics Conference, İstanbul, Turkey, 7 - 10 July 2007, pp.202, (Summary Text)

190. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)

191. The incidence of Ph chromosome and Trisomy 8 in chronic myeloid patients

20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.548-549, (Summary Text)

193. Determination of cytokine gene polymorphisms in patients with multiple myeloma

20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.542-543, (Summary Text)

194. HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma

20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.533-534, (Summary Text)

196. Allogeneik Kök Hücre Nakli Sonrası Kimerizmin Değerlendirilmesinde FISH ve STR-PCR Yöntemleri.

IX. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Manisa, Turkey, 24 - 27 November 2005, pp.115, (Full Text)

197. Chimerism monitoring by short tandem repeat (STR) analysis in HSCT

19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6, (Summary Text)

198. The association between HLA markers and oral mucositis in allogeneic hematopoietic cell transplantation

19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6, (Summary Text)

199. The relationship between HLA antigens and CMV infection after HSCT: A single center experience from Turkey

19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6, (Summary Text)

200. The relationship between minor histocompatibility antigens and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Czech Republic, 20 - 23 March 2005, vol.35, (Summary Text)

202. The negative impact of stem cell transplantation on psychological status; a single-centre experience

30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33, (Summary Text)

203. Incidence and outcome of renal dysfunction early in the course of haematopoietic cell transplantation

30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33, (Summary Text)

204. Quality of life assessment of haematopoietic stem cell transplantation patients in Istanbul: a pilot study

30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33, (Summary Text)

205. The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)

206. Oral lesions and hygiene in stem cell recipients with graft versus host disease.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)

207. Interleukin-6 gene polymorphisms associate with acute graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)

208. Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease: Turkish experience

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)

209. Effect of methylenetetrahydrofolate reductase gene polymorphism on methotrexate toxicity after bone marrow transplantation

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)

210. Unrelated hematopoietic stem cell transplantation: Istanbul University/Istanbul medical faculty bone marrow registry (Kibank): a pioneering role in turkey

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)

211. HLA full match donors

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31

212. What people having hematologic malignancies and people of good health think about infertility

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) Sustainable Development

213. Change in serum procalcitonin has diagnostic and prognostic value for most early complications in stem cell transplantation

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)

214. The effect of stem cell transplantation on social and economic status in a developing country on family basis

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)

215. Procalcitonin in stem cell transplantation: It has highly diagnostic and prognostic value for most early complications.

44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100, (Summary Text)
Books 20

2. COMPLICATIONS IN TRANSFUSION-DEPENDENT THALASSEMIA: A HEMATOLOGICAL PERSPECTIVE

in: ENDOCRINE COMPLICATIONS IN THALASSEMIA, Zeynep Karakaş,Nurdan Gül,Hikmet Gülşah Tanyıldız, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.1-5, 2026

3. OLGULARLA TRANSFÜZYON BULMACALARI

in: Acil Dahiliye, Kerim Güler,Semra Çalangu, Editor, Nobel Yayın Dağıtım, İstanbul, pp.1-2, 2025

4. Acil Polikliniğe Başvuran Hastalarda Hemogramın Değerlendirilmesi

in: Dahili - Cerrahi - Adli -Aciller El Kitabı, rof. Dr. Mehmet Şükrü Sever,Doç. Dr. Halil Yazıcı,Pof. Dr. Tevfik Ecder, Editor, Nobel Yayın Dağıtım, İstanbul, pp.555-587, 2024

6. Kalp Transplantasyonunda Güncel Hematolojik İzlem ve Yaklaşımlar

in: Kalp Transplantasyonunda Güncel Yaklaşımlar, Nilgün Bozbuğa, Editor, Türkiye Klinikleri, Ankara, pp.142-149, 2023

7. Herediter Plazminojen Eksikliği İlişkili Lignöz Konjonktivit

in: OLGULARLA KANAYAN ÇOCUK, AYŞEGÜL ÜNÜVAR, CANAN ALBAYRAK, DİLEK GÜRLEK GÖKÇEBAY, ELİF GÜLER KAZANCI, KAHRAMAN ÖNCEL, Editor, GALENOS, İstanbul, pp.35-40, 2023

8. Herediter Plazminojen Eksikliği İlişkili Lignöz Konjonktivit

in: Olgularla Kanayan Çocuk, Ayşegül Ünüvar, Canan Bayrak,Dilek Gökçebay, Elif Gürler Kazancı, Kahraman Öncel, Editor, Galenos, pp.35-41, 2023

10. HEMATOLOJİK HASTALIKLARDA ORAL DİAGNOZ

in: Multidisipliner Prensiplerle Oral Diagnoz, İlknur Özcan, Editor, İstanbul Tıp Kitapevi, İstanbul, pp.150-153, 2022

11. Kanama ve Koagülasyon Bozuklukları

in: TRAVMA, Cemalettin ERTEKİN, Editor, EMA Tıp Kitabevi Yayıncılık Tic. Ltd. Şti., İstanbul, pp.1326-1332, 2022

12. MULTIPLE MYELOMA AND IMMUNE MODULATORS

in: Advances in Medicine and Health Science Researches and Practice, Prof. Dr. Halit DEMİR Asst. Prof. Dr. Mehmet Okan DONBALOĞLU, Editor, by Livre de Lyon, Lyon, pp.103-110, 2022

13. Hodgkin Dışı Lenfomalarda Hedefe Yönelik Tedaviler

in: Hematolojik Kanserlerde Hedefe Yönelik Tedaviler, İlhami Kiki, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.35-44, 2021 Sustainable Development

14. Anemi

in: Geriatri Yaşlı Sağlığı ve Hastalıkları, Prof. Dr. Zekeriya Ülger Prof. Dr. Ü. Deniz Erdinçler Prof. Dr. Mehmet Akif Karan, Editor, HİPOKRAT, Ankara, pp.1-14, 2021 Creative Commons License

15. Endotel Hastalıkları ve Hematolojik Komplikasyonlar

in: İmmünohematolojide Güncel Başlıklar, Gülsan Türköz Sucak, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.25-30, 2021

16. Hodgkin Dışı Lenfomalarda Hedefe Yönelik Tedaviler

in: HEMATOLOJİK KANSERLERDE HEDEFE YÖNELİK TEDAVİLER, KİKİ İLHAMİ, Editor, Türkiye Klinikleri Hematoloji, Ankara, pp.35-44, 2021 Sustainable Development

18. COVID-19'da Hematolojik Bulgular

in: Halk Sağlığı ve COVID-19, Önal AE, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.56-60, 2020 Sustainable Development

19. Multipl Miyelomda Böbrek Hastalığına Tedavi Yaklaşımı

in: Türkiye Klinikleri Hematoloji, Multipl Miyelom Özel Sayısı, GÖKER HAKAN, Editor, Türkiye Klinikleri Hematoloji, Ankara, pp.53-58, 2019
Metrics

Publication

458

Publication (WoS)

270

Publication (Scopus)

197

Citation (WoS)

1322

H-Index (WoS)

18

Citation (Scopus)

1736

H-Index (Scopus)

20

Citation (Scholar)

81

H-Index (Scholar)

5

Citation (TrDizin)

4

H-Index (TrDizin)

1

Citation (Sum Other)

4

Total Citation Count

1330

Project

15

Thesis Advisory

32

Open Access

32
UN Sustainable Development Goals